Replies to post #108773 on Biotech Values

[DewDiligence]

Delaware’s Supreme Court reversed the opinion by the Delaware Chancery Court in the APD-ARG case, which has ramifications for all companies with staggered BoD’s:

http://www.bloomberg.com/news/2010-11-23/airgas-wins-ruling-on-annual-meeting-date-in-bid-to-fend-off-air-products.html

Many biotech companies have staggered BoD’s. So do about 30% of companies in the S&P 500.